Cathrine A. Miner

1.5k total citations
20 papers, 786 citations indexed

About

Cathrine A. Miner is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Cathrine A. Miner has authored 20 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Cathrine A. Miner's work include Immune Cell Function and Interaction (6 papers), interferon and immune responses (5 papers) and T-cell and B-cell Immunology (5 papers). Cathrine A. Miner is often cited by papers focused on Immune Cell Function and Interaction (6 papers), interferon and immune responses (5 papers) and T-cell and B-cell Immunology (5 papers). Cathrine A. Miner collaborates with scholars based in United States, Australia and France. Cathrine A. Miner's co-authors include Jonathan J. Miner, Derek J. Platt, Brock G. Bennion, Olga Malkova, Carol F. Webb, Teresa L. Ai, Amber M. Smith, Amy Zhou, Elizabeth K. Engle and Stephen T. Oh and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Cathrine A. Miner

19 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathrine A. Miner United States 14 474 430 143 130 113 20 786
Nagaja Capitani Italy 16 343 0.7× 282 0.7× 182 1.3× 46 0.4× 38 0.3× 41 695
Caryll Waugh Australia 11 274 0.6× 299 0.7× 59 0.4× 48 0.4× 54 0.5× 12 628
Dennis A. Carson United States 12 277 0.6× 173 0.4× 124 0.9× 41 0.3× 66 0.6× 17 599
Sonja Meixlsperger Germany 11 595 1.3× 228 0.5× 86 0.6× 43 0.3× 106 0.9× 14 918
Gabriele Beck‐Engeser United States 19 563 1.2× 465 1.1× 44 0.3× 39 0.3× 42 0.4× 31 1.0k
Gitta Anne Heinz Germany 13 416 0.9× 475 1.1× 42 0.3× 30 0.2× 54 0.5× 27 962
Shinichiro Yoshida Japan 16 709 1.5× 218 0.5× 71 0.5× 16 0.1× 162 1.4× 65 1.2k
Irina Kondratenko Russia 13 361 0.8× 470 1.1× 63 0.4× 51 0.4× 80 0.7× 25 872
Pin-Yi Wang United States 14 257 0.5× 258 0.6× 44 0.3× 40 0.3× 93 0.8× 32 792
Christiane Guret United States 12 663 1.4× 234 0.5× 120 0.8× 24 0.2× 41 0.4× 15 1.0k

Countries citing papers authored by Cathrine A. Miner

Since Specialization
Citations

This map shows the geographic impact of Cathrine A. Miner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathrine A. Miner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathrine A. Miner more than expected).

Fields of papers citing papers by Cathrine A. Miner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathrine A. Miner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathrine A. Miner. The network helps show where Cathrine A. Miner may publish in the future.

Co-authorship network of co-authors of Cathrine A. Miner

This figure shows the co-authorship network connecting the top 25 collaborators of Cathrine A. Miner. A scholar is included among the top collaborators of Cathrine A. Miner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathrine A. Miner. Cathrine A. Miner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGlasson, Sarah, Kayleigh M. Reid, Anna Klingseisen, et al.. (2025). Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel disease. Brain. 148(8). 2981–2994.
2.
Chauvin, Samuel D., et al.. (2024). Prime Editor Gene Therapy and TREX1 Mosaicism in Retinal Vasculopathy with Cerebral Leukoencephalopathy. Journal of Clinical Immunology. 45(1). 54–54. 2 indexed citations
3.
Stinson, William A., et al.. (2022). The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice. JCI Insight. 7(17). 14 indexed citations
4.
Platt, Derek J., Rachel Rodgers, Lawrence A. Schriefer, et al.. (2021). Transferrable protection by gut microbes against STING-associated lung disease. Cell Reports. 35(6). 109113–109113. 14 indexed citations
5.
Fisher, Daniel A.C., Cathrine A. Miner, Elizabeth K. Engle, et al.. (2019). Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling. Leukemia. 33(8). 1978–1995. 93 indexed citations
6.
Luksch, Hella, William A. Stinson, Derek J. Platt, et al.. (2019). STING-associated lung disease in mice relies on T cells but not type I interferon. Journal of Allergy and Clinical Immunology. 144(1). 254–266.e8. 84 indexed citations
7.
Qian, Wei, Cathrine A. Miner, Harshad Ingle, et al.. (2019). A Human STAT1 Gain-of-Function Mutation Impairs CD8 + T Cell Responses against Gammaherpesvirus 68. Journal of Virology. 93(19). 11 indexed citations
8.
Bennion, Brock G., Harshad Ingle, Teresa L. Ai, et al.. (2018). A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice. Journal of Virology. 93(4). 47 indexed citations
9.
Irizarry-Caro, Ricardo A., Brock G. Bennion, Teresa L. Ai, et al.. (2017). STING-associated vasculopathy develops independently of IRF3 in mice. The Journal of Experimental Medicine. 214(11). 3279–3292. 142 indexed citations
10.
Yeang, Han Xian Aw, Sytse J. Piersma, Yiing Lin, et al.. (2017). Cutting Edge: Human CD49e− NK Cells Are Tissue Resident in the Liver. The Journal of Immunology. 198(4). 1417–1422. 67 indexed citations
11.
Yeang, Han Xian Aw, Yiing Lin, Olga Malkova, et al.. (2016). Human liver contains two populations of NK cells based on CD49e expression. The Journal of Immunology. 196(1_Supplement). 194.7–194.7. 1 indexed citations
12.
Fisher, D., Olga Malkova, Elizabeth K. Engle, et al.. (2016). Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia. Leukemia. 31(9). 1962–1974. 70 indexed citations
13.
Fisher, Daniel A.C., et al.. (2016). Mass Cytometry Analysis of Dysregulated Cytokine Production and Intracellular Signaling in Myelofibrosis. Blood. 128(22). 4277–4277. 2 indexed citations
14.
Miner, Cathrine A., Tusar Giri, Claire E. Meyer, Mark Shabsovich, & Sandeep K. Tripathy. (2015). Acquisition of Activation Receptor Ligand by Trogocytosis Renders NK Cells Hyporesponsive. The Journal of Immunology. 194(4). 1945–1953. 27 indexed citations
15.
Rhee, Catherine, He Li, Cathrine A. Miner, et al.. (2014). Bright/Arid3A Acts as a Barrier to Somatic Cell Reprogramming through Direct Regulation of Oct4, Sox2, and Nanog. Stem Cell Reports. 2(1). 26–35. 41 indexed citations
16.
Miner, Cathrine A., et al.. (2013). An essential and NSF independent role for α-SNAP in store-operated calcium entry. eLife. 2. e00802–e00802. 34 indexed citations
17.
Oldham, Athenia L., Cathrine A. Miner, Hongcheng Wang, & Carol F. Webb. (2011). The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production. Molecular Immunology. 49(1-2). 367–379. 13 indexed citations
18.
Webb, Carol F., June V. Harriss, Christian Schmidt, et al.. (2011). The ARID Family Transcription Factor Bright Is Required for both Hematopoietic Stem Cell and B Lineage Development. Molecular and Cellular Biology. 31(5). 1041–1053. 63 indexed citations
19.
An, Guangyu, et al.. (2010). Loss of Bright/ARID3a Function Promotes Developmental Plasticity. Stem Cells. 28(9). 1560–1567. 41 indexed citations
20.
Miner, Cathrine A., et al.. (2008). Transgenic Mice Expressing Dominant-Negative Bright Exhibit Defects in B1 B Cells. The Journal of Immunology. 181(10). 6913–6922. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nagaja Capitani Breakdown of academic impact, for papers by Caryll Waugh Breakdown of academic impact, for papers by Dennis A. Carson Breakdown of academic impact, for papers by Sonja Meixlsperger Breakdown of academic impact, for papers by Gabriele Beck‐Engeser Breakdown of academic impact, for papers by Gitta Anne Heinz Breakdown of academic impact, for papers by Shinichiro Yoshida Breakdown of academic impact, for papers by Irina Kondratenko Breakdown of academic impact, for papers by Pin-Yi Wang Breakdown of academic impact, for papers by Christiane Guret
Rankless by CCL
2026